BMS-986504

Clinical trials for BMS-986504 explained in plain language.

Never miss a new study

Get alerted when new BMS-986504 trials appear

Sign up with your email to follow new studies for BMS-986504, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo targets Hard-to-Treat pancreatic cancer

Disease control Recruiting now

This study tests whether adding the drug BMS-986504 to standard chemotherapy can help control pancreatic cancer in people whose tumors have a specific genetic change (MTAP deletion). About 60 adults with this cancer type will receive the combination either before and after surger…

Matched conditions: BMS-986504

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 26, 2026 12:00 UTC

BMS-986504

Get alerted when new BMS-986504 trials appear

New drug combo targets Hard-to-Treat pancreatic cancer